MedPath

Intraoperative bile duct visualisation in children with biliary atresia using a fluorescence camera system: a pilot study - Bile duct mapping with fluorescence in BA

Conditions
Biliary atresia
Registration Number
EUCTR2009-014886-21-NL
Lead Sponsor
niversity Medical Centre Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
4
Inclusion Criteria

Patients with suspected biliary atresia.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

History of iodine allergy or anaphylactic reactions to insect bites or medication. Presence or history of hyperthyroidism. Severe renal or liver failure.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: The primary objective is to confirm the diagnosis of biliary atresia by visualisation of the (remaining) biliary tract using fluorescence cholangiography.;Secondary Objective: None;Primary end point(s): The main endpoint is confirmation of the diagnosis biliary atresia, defined as fluorescent signal in the liver and possibly proximal remaining biliary structures without continuation into the duodenum.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath